Cargando…

Searching for the one(s): Using Probiotics as Anthelmintic Treatments

Helminths are a major health concern as over one billion people are infected worldwide and, despite the multiple efforts made, there is still no effective human vaccine against them. The most important drugs used nowadays to control helminth infections belong to the benzimidazoles, imidazothiazoles...

Descripción completa

Detalles Bibliográficos
Autores principales: Saracino, Maria Priscila, Vila, Cecilia Celeste, Baldi, Pablo César, González Maglio, Daniel Horacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381770/
https://www.ncbi.nlm.nih.gov/pubmed/34434110
http://dx.doi.org/10.3389/fphar.2021.714198
_version_ 1783741432743329792
author Saracino, Maria Priscila
Vila, Cecilia Celeste
Baldi, Pablo César
González Maglio, Daniel Horacio
author_facet Saracino, Maria Priscila
Vila, Cecilia Celeste
Baldi, Pablo César
González Maglio, Daniel Horacio
author_sort Saracino, Maria Priscila
collection PubMed
description Helminths are a major health concern as over one billion people are infected worldwide and, despite the multiple efforts made, there is still no effective human vaccine against them. The most important drugs used nowadays to control helminth infections belong to the benzimidazoles, imidazothiazoles (levamisole) and macrocyclic lactones (avermectins and milbemycins) families. However, in the last 20 years, many publications have revealed increasing anthelmintic resistance in livestock which is both an economical and a potential health problem, even though very few have reported similar findings in human populations. To deal with this worrying limitation of anthelmintic drugs, alternative treatments based on plant extracts or probiotics have been developed. Probiotics are defined by the Food and Agriculture Organization as live microorganisms, which, when consumed in adequate amounts, confer a health benefit to the host. It has been proven that probiotic microbes have the ability to exert an immunomodulatory effect both at the mucosa and the systemic level. The immune response against gastrointestinal helminths is characterized as a type 2 response, with high IgE levels, increased numbers and/or activity of Th2 cells, type 2 innate lymphoid cells, eosinophils, basophils, mast cells, and alternatively activated macrophages. The oral administration of probiotics may contribute to controlling gastrointestinal helminth infections since it has been demonstrated that these microorganisms stimulate dendritic cells to elicit a type 2 or regulatory immune response, among other effects on the host immune system. Here we review the current knowledge about the use of probiotic bacteria as anthelmintic therapy or as a complement to traditional anthelmintic treatments. Considering all research papers reviewed, we may conclude that the effect generated by probiotics on helminth infection depends not only on the parasite species, their stage and localization but also on the administration scheme.
format Online
Article
Text
id pubmed-8381770
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83817702021-08-24 Searching for the one(s): Using Probiotics as Anthelmintic Treatments Saracino, Maria Priscila Vila, Cecilia Celeste Baldi, Pablo César González Maglio, Daniel Horacio Front Pharmacol Pharmacology Helminths are a major health concern as over one billion people are infected worldwide and, despite the multiple efforts made, there is still no effective human vaccine against them. The most important drugs used nowadays to control helminth infections belong to the benzimidazoles, imidazothiazoles (levamisole) and macrocyclic lactones (avermectins and milbemycins) families. However, in the last 20 years, many publications have revealed increasing anthelmintic resistance in livestock which is both an economical and a potential health problem, even though very few have reported similar findings in human populations. To deal with this worrying limitation of anthelmintic drugs, alternative treatments based on plant extracts or probiotics have been developed. Probiotics are defined by the Food and Agriculture Organization as live microorganisms, which, when consumed in adequate amounts, confer a health benefit to the host. It has been proven that probiotic microbes have the ability to exert an immunomodulatory effect both at the mucosa and the systemic level. The immune response against gastrointestinal helminths is characterized as a type 2 response, with high IgE levels, increased numbers and/or activity of Th2 cells, type 2 innate lymphoid cells, eosinophils, basophils, mast cells, and alternatively activated macrophages. The oral administration of probiotics may contribute to controlling gastrointestinal helminth infections since it has been demonstrated that these microorganisms stimulate dendritic cells to elicit a type 2 or regulatory immune response, among other effects on the host immune system. Here we review the current knowledge about the use of probiotic bacteria as anthelmintic therapy or as a complement to traditional anthelmintic treatments. Considering all research papers reviewed, we may conclude that the effect generated by probiotics on helminth infection depends not only on the parasite species, their stage and localization but also on the administration scheme. Frontiers Media S.A. 2021-08-09 /pmc/articles/PMC8381770/ /pubmed/34434110 http://dx.doi.org/10.3389/fphar.2021.714198 Text en Copyright © 2021 Saracino, Vila, Baldi and González Maglio. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Saracino, Maria Priscila
Vila, Cecilia Celeste
Baldi, Pablo César
González Maglio, Daniel Horacio
Searching for the one(s): Using Probiotics as Anthelmintic Treatments
title Searching for the one(s): Using Probiotics as Anthelmintic Treatments
title_full Searching for the one(s): Using Probiotics as Anthelmintic Treatments
title_fullStr Searching for the one(s): Using Probiotics as Anthelmintic Treatments
title_full_unstemmed Searching for the one(s): Using Probiotics as Anthelmintic Treatments
title_short Searching for the one(s): Using Probiotics as Anthelmintic Treatments
title_sort searching for the one(s): using probiotics as anthelmintic treatments
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381770/
https://www.ncbi.nlm.nih.gov/pubmed/34434110
http://dx.doi.org/10.3389/fphar.2021.714198
work_keys_str_mv AT saracinomariapriscila searchingfortheonesusingprobioticsasanthelmintictreatments
AT vilaceciliaceleste searchingfortheonesusingprobioticsasanthelmintictreatments
AT baldipablocesar searchingfortheonesusingprobioticsasanthelmintictreatments
AT gonzalezmagliodanielhoracio searchingfortheonesusingprobioticsasanthelmintictreatments